Abstract:Introduction. Placement of the central vein catheterization (CVC) is a major risk factor for central vein stenosis (CVS). Repetitive endothelial exposures to the CVC results in inflammation, microthrombi formation, hyperplasia of the intima, fibrosis and thus development of CVS. The study aimed to find out the correlation between the duration and frequency of CVC in patients with CVS. Method. A matched case-control study was conducted in dr. Cipto Mangunkusumo General Hospital. Samples were taken from the medi… Show more
“…4 The prevalence of central venous stenosis in America was by 29%, for Cipto Mangunkusumo hospital was by 7.53%, while in Pelni hospital prevalence rate was by 13.5%. 7 Previous studies revealed that the mortality rate was 4 times higher in patients with renal failure when surgery was performed. This is due to the comorbid conditions that accompany patients with renal failures, such as systemic arteriosclerosis, chronic inflammation, malnutrition.…”
Introduction: Many causes leads to kidney impairment. This does not rule out the increasing number of patients undergoing hemodialysis. The common vascular access used during hemodialysis is an arteriovenous fistula (AVF). The arteriovenous fistula was preferred because it lasts longer and has a lower risk of infection for vascular access, meanwhile central venous stenosis or occlusion in the vein that carries the blood from the extremities to the heart often occur. If vascular access is still used during hemodialysis in which central venous stenosis is formed, it needs to make a new vascular access option. Percutaneous transluminal angiography (PTA) main objectives are to dilate the venous lesion that has occlusion more than 50% and extending the lifespan of arteriovenous fistula. In this case, we report six patients hemodialysis with central venous stenosis treated with percutaneous transluminal angiography. This procedure has benefits that are arteriovenous fistula can be used again to reach hemodialysis adequacy optimally and reduce pain and swelling in the arms.
Case description: There six cases who were 45,48,57.58,63 and 66 years old who underwent percutaneous transluminal angioplasty procedures for central venous stenosis. Several past illnesses of the patients underlying the kidney impairment such chronic hypertension, chronic coronary heart complications, and/or diabetes. Several patients felt AVF swollen and/or painful. Minimal residual stenosis after balloon angioplasty was performed.
Conclusion: According to our cases, patients that underwent the hemodialysis felt swollen or/and pain due to stenosis ballooning angioplasty help minimize the residual stenosis.
“…4 The prevalence of central venous stenosis in America was by 29%, for Cipto Mangunkusumo hospital was by 7.53%, while in Pelni hospital prevalence rate was by 13.5%. 7 Previous studies revealed that the mortality rate was 4 times higher in patients with renal failure when surgery was performed. This is due to the comorbid conditions that accompany patients with renal failures, such as systemic arteriosclerosis, chronic inflammation, malnutrition.…”
Introduction: Many causes leads to kidney impairment. This does not rule out the increasing number of patients undergoing hemodialysis. The common vascular access used during hemodialysis is an arteriovenous fistula (AVF). The arteriovenous fistula was preferred because it lasts longer and has a lower risk of infection for vascular access, meanwhile central venous stenosis or occlusion in the vein that carries the blood from the extremities to the heart often occur. If vascular access is still used during hemodialysis in which central venous stenosis is formed, it needs to make a new vascular access option. Percutaneous transluminal angiography (PTA) main objectives are to dilate the venous lesion that has occlusion more than 50% and extending the lifespan of arteriovenous fistula. In this case, we report six patients hemodialysis with central venous stenosis treated with percutaneous transluminal angiography. This procedure has benefits that are arteriovenous fistula can be used again to reach hemodialysis adequacy optimally and reduce pain and swelling in the arms.
Case description: There six cases who were 45,48,57.58,63 and 66 years old who underwent percutaneous transluminal angioplasty procedures for central venous stenosis. Several past illnesses of the patients underlying the kidney impairment such chronic hypertension, chronic coronary heart complications, and/or diabetes. Several patients felt AVF swollen and/or painful. Minimal residual stenosis after balloon angioplasty was performed.
Conclusion: According to our cases, patients that underwent the hemodialysis felt swollen or/and pain due to stenosis ballooning angioplasty help minimize the residual stenosis.
“…Clinical manifestations include pain; superior extremities and facial edema; dilatation of collateral veins in the face, neck, and chest; tissue damage and ulceration. 5 The incidence of CVS in the population routinely undergoing HD is 14% in the United States, and in Canada is 23%-29%, but the data have not been obtained in Indonesia. 6 The risk factors for CVS include the location of the CVC, the type and material of the catheter, the length of time the catheter was inserted, a history of the previous CVC placement, and a long duration of catheter insertion (> 6 weeks).…”
Background: Central vein stenosis (CVS) is a common complication in using a central venous catheter in hemodialysis (HD) access, and its incidence in Indonesia has not been obtained. This study aims to evaluate the characteristics of CVS patients in Abdul Wahab Sjahranie Hospital, Samarinda.
Methods: This cross-sectional descriptive study was conducted by collecting CVS patients’ data from the medical records between January 2018 to August 2021. The demographic data and the characteristics of CVS patients were collected. The data obtained were analyzed in descriptive form and displayed in a table.
Results: This study involved 23 subjects. The characteristics of CVS patients included: Highest sex group was males (61%); Age group was in the range 51-70 years (60%); Clinical feature was swelling (83%); Site of stenosis was in the subclavian vein (87%), on the left side (57%), type of occlusion were partial (67%) and single (87%), and the result of angioplasty was a success (61%).
Conclusion: This study showed that CVS was male predominant, in the range 51-70 years, the most complaint was swelling in the arms that were mostly on the left side, and the location of the most stenosis was in the subclavian vein, with partial and single occlusion, as well as good treatment with angioplasty.
Background
The right internal jugular vein is currently recommended for temporary central dialysis catheters (tCDC) based on results from previous studies showing a lower incidence of central vein stenosis compared to the subclavian vein. Data is however conflicting, and there are several advantages when the subclavian route is used for tCDCs. This prospective, controlled, randomised, non-inferiority study aims to compare the incidence of post-catheterisation central vein stenosis between the right subclavian and the right internal jugular routes.
Methods
Adult patients needing a tCDC will be included from several hospitals and randomised to either subclavian or internal jugular vein catheterisation with a silicone tCDC. Inclusion continues until 50 patients in each group have undergone a follow-up CT venography. The primary outcome is the incidence of post-catheterisation central vein stenosis detected by a CT venography performed 1.5 to 3 months after removal of the tCDC. Secondary outcomes include between-group comparisons of (I) the patients’ experience of discomfort and pain, (II) any dysfunction of the tCDC during use, (III) catheterisation success rate and (IV) the number of mechanical complications. Furthermore, the ability to detect central vein stenosis by a focused ultrasound examination will be evaluated using the CT venography as golden standard.
Discussion
The use of the subclavian route for tCDC placement has largely been abandoned due to older studies with various methodological issues. However, the subclavian route offers several advantages for the patient. This trial is designed to provide robust data on the incidence of central vein stenosis after silicone tCDC insertion in the era of ultrasound-guided catheterisations.
Trial registration
Clinicaltrials.gov; NCT04871568. Prospectively registered on May 4, 2021.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.